ANDA 85113, held by Impax Labs. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 85113 (Chlordiazepoxide Hydrochloride), held by Impax Labs, was first approved by FDA on Dec 12, 1977, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 12, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride10MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
| Sep 17, 1992 | Supplement 11Labeling | Approved | None posted |
| Sep 17, 1991 | Supplement 10Labeling | Approved | None posted |
| Jul 9, 1990 | Supplement 9Labeling | Approved | None posted |
| Oct 24, 1989 | Supplement 8Labeling | Approved | None posted |
| Jan 11, 1989 | Supplement 7Labeling | Approved | None posted |
| Dec 12, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters